The United Laboratories International Holdings Limited (3933.HK)

HKD 13.38

(0.45%)

Total Assets Summary of The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited's latest annual total assets in 2023 was 21.01 Billion CNY , up 10.74% from previous year.
The United Laboratories International Holdings Limited's latest quarterly total assets in 2024 Q2 was 22.82 Billion CNY , down 0.0% from previous quarter.
The United Laboratories International Holdings Limited reported annual total assets of 18.97 Billion CNY in 2022, up 16.22% from previous year.
The United Laboratories International Holdings Limited reported annual total assets of 16.33 Billion CNY in 2021, up 9.14% from previous year.
The United Laboratories International Holdings Limited reported quarterly total assets of 19.76 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
The United Laboratories International Holdings Limited reported quarterly total assets of 21.01 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of The United Laboratories International Holdings Limited (2023 - 2006)

Historical Annual Total Assets of The United Laboratories International Holdings Limited (2023 - 2006)

Year	Total Assets	Total Assets Growth
2023	21.01 Billion CNY	10.74%
2022	18.97 Billion CNY	16.22%
2021	16.33 Billion CNY	9.14%
2020	14.96 Billion CNY	-4.69%
2019	15.69 Billion CNY	7.52%
2018	14.6 Billion CNY	3.48%
2017	14.11 Billion CNY	-5.71%
2016	14.96 Billion CNY	2.63%
2015	14.58 Billion CNY	-3.62%
2014	15.13 Billion CNY	-1.13%
2013	15.3 Billion CNY	17.75%
2012	12.99 Billion CNY	35.35%
2011	9.6 Billion CNY	17.28%
2010	8.18 Billion CNY	24.66%
2009	6.56 Billion CNY	20.89%
2008	5.43 Billion CNY	22.09%
2007	4.44 Billion CNY	19.55%
2006	3.72 Billion CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	22.82 Billion CNY	0.0%
2023 Q2	19.76 Billion CNY	0.0%
2023 Q4	21.01 Billion CNY	0.0%
2023 FY	21.01 Billion CNY	10.74%
2022 Q4	18.97 Billion CNY	0.0%
2022 FY	18.97 Billion CNY	16.22%
2022 Q2	17.35 Billion CNY	0.0%
2021 Q2	15.84 Billion CNY	0.0%
2021 FY	16.33 Billion CNY	9.14%
2021 Q4	16.33 Billion CNY	0.0%
2020 Q2	15.13 Billion CNY	0.0%
2020 Q4	14.96 Billion CNY	0.0%
2020 FY	14.96 Billion CNY	-4.69%
2019 Q2	15.26 Billion CNY	0.0%
2019 FY	15.69 Billion CNY	7.52%
2019 Q4	15.69 Billion CNY	0.0%
2018 Q2	14.41 Billion CNY	0.0%
2018 Q4	14.6 Billion CNY	0.0%
2018 FY	14.6 Billion CNY	3.48%
2017 FY	14.11 Billion CNY	-5.71%
2017 Q4	14.11 Billion CNY	0.0%
2017 Q2	14.77 Billion CNY	0.0%
2016 Q4	14.96 Billion CNY	0.0%
2016 FY	14.96 Billion CNY	2.63%
2016 Q2	14.69 Billion CNY	0.0%
2015 FY	14.58 Billion CNY	-3.62%
2015 Q2	15.03 Billion CNY	0.0%
2015 Q4	14.58 Billion CNY	0.0%
2014 Q2	15.57 Billion CNY	0.0%
2014 Q4	15.13 Billion CNY	0.0%
2014 FY	15.13 Billion CNY	-1.13%
2013 Q2	13.97 Billion CNY	0.0%
2013 FY	15.3 Billion CNY	17.75%
2013 Q4	15.31 Billion CNY	0.0%
2012 Q2	11.01 Billion CNY	0.0%
2012 Q4	12.99 Billion CNY	0.0%
2012 FY	12.99 Billion CNY	35.35%
2011 Q4	9.6 Billion CNY	0.0%
2011 Q2	8.94 Billion CNY	0.0%
2011 FY	9.6 Billion CNY	17.28%
2010 Q4	8.18 Billion CNY	0.0%
2010 FY	8.18 Billion CNY	24.66%
2010 Q2	7.61 Billion CNY	0.0%
2009 Q4	6.56 Billion CNY	0.0%
2009 FY	6.56 Billion CNY	20.89%
2008 FY	5.43 Billion CNY	22.09%
2007 FY	4.44 Billion CNY	19.55%
2006 FY	3.72 Billion CNY	0.0%

Peer Total Assets Comparison of The United Laboratories International Holdings Limited

Name	Total Assets	Total Assets Difference
Pak Fah Yeow International Limited	907.46 Million HKD	-2216.032%
Grand Pharmaceutical Group Limited	22.51 Billion HKD	6.654%
Extrawell Pharmaceutical Holdings Limited	1.28 Billion HKD	-1532.797%
Wai Yuen Tong Medicine Holdings Limited	2.09 Billion HKD	-903.154%
Qianhai Health Holdings Limited	478.11 Million HKD	-4295.824%
Lee's Pharmaceutical Holdings Limited	2.89 Billion HKD	-627.07%
Essex Bio-Technology Limited	2.82 Billion HKD	-643.298%
Tongfang Kontafarma Holdings Limited	1.72 Billion HKD	-1116.74%
PuraPharm Corporation Limited	843.96 Million HKD	-2390.296%
SSY Group Limited	11.96 Billion HKD	-75.636%
JBM (Healthcare) Limited	1.38 Billion HKD	-1413.446%
Jacobson Pharma Corporation Limited	3.48 Billion HKD	-502.755%
China Resources Pharmaceutical Group Limited	271.69 Billion HKD	92.264%